Monday, February 13, 2017Akebia Licenses Portfolio of Novel HIF Compounds from Johnson & Johnson Innovation
Friday, February 3, 2017Akebia to Present at the 19th BIO CEO & Investor Conference
Tuesday, December 20, 2016Akebia and Otsuka Pharmaceutical Announce Collaboration to Develop and Commercialize Vadadustat in the U.S.
Monday, December 12, 2016Akebia Prevails in Additional European Patent Dispute
Friday, December 2, 2016Akebia Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Wednesday, November 9, 2016Akebia Announces Third Quarter 2016 Financial Results
Monday, October 31, 2016Akebia to Present at the Credit Suisse 25th Annual Healthcare Conference
Monday, October 17, 2016Akebia Announces Presentations at the Upcoming American Society of Nephrology Kidney Week 2016 Annual Meeting
Monday, September 26, 2016Akebia Announces Publication Highlighting Potential Benefits of HIF Treatments for Patients with Renal Anemia
Monday, September 19, 2016Akebia Announces Publication of Phase 2b Data for Vadadustat in Non-Dialysis Patients with Anemia Related to Chronic Kidney Disease
Tuesday, September 6, 2016Akebia to Present at Upcoming Investor Conferences
Monday, August 22, 2016Akebia Announces Publication Highlighting Need for New Solutions in Treating Dialysis Patients
View all press releases »
Downloadable tools, news, and press releases
© 2017 Akebia Therapeutics. All rights reserved.